Dr. Richard Green, MD
Claim this profileKaiser Permanente Los Angeles Medical Center
Area of expertise
Brain Tumor
Richard Green, MD has run 8 trials for Brain Tumor. Some of their research focus areas include:
Glioblastoma
Richard Green, MD has run 7 trials for Glioblastoma. Some of their research focus areas include:
Affiliated Hospitals
Kaiser Permanente Los Angeles Medical Center
Kaiser Permanente-Anaheim
Clinical Trials Richard Green, MD is currently running
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting
1 award
Phase 2
10 criteria
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting
2 awards
Phase 3
4 criteria
More about Richard Green, MD
Clinical Trial Related
10 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Richard Green, MD has experience with
- Lomustine
- Nivolumab
- Temozolomide
- Chemotherapy
- ChemoID Assay
- Berubicin
Breakdown of trials Richard Green, MD has run
Brain Tumor
Glioblastoma
Gliosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Richard Green, MD specialize in?
Richard Green, MD focuses on Brain Tumor and Glioblastoma. In particular, much of their work with Brain Tumor has involved IDH positive patients, or patients who are 1p/19q co-deletion positive.
Is Richard Green, MD currently recruiting for clinical trials?
Yes, Richard Green, MD is currently recruiting for 4 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Richard Green, MD has studied deeply?
Yes, Richard Green, MD has studied treatments such as Lomustine, Nivolumab, Temozolomide.
What is the best way to schedule an appointment with Richard Green, MD?
Apply for one of the trials that Richard Green, MD is conducting.
What is the office address of Richard Green, MD?
The office of Richard Green, MD is located at: Kaiser Permanente Los Angeles Medical Center, Los Angeles, California 90027 United States. This is the address for their practice at the Kaiser Permanente Los Angeles Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.